INTEGRA LIFESCIENCES HOLDINGS CORP Proceeds from Derivative Instrument, Investing Activities
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Proceeds from Derivative Instrument, Investing Activities of $76.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities · last filed 2021-11-02
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from derivative instrument, investing activities for fiscal 2019 was $1.58M.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from derivative instrument, investing activities for fiscal 2018 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP proceeds from derivative instrument, investing activities for fiscal 2017 was $0.00.
| Period end | Proceeds from Derivative Instrument, Investing Activities 9 month | Proceeds from Derivative Instrument, Investing Activities 12 month |
|---|---|---|
| 2021-09-30 | $76.00K 10-Q · filed 2021-11-02 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $1.58M 10-K · filed 2020-02-21 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-21 | |
| 2017-12-31 | $0.00 10-K · filed 2020-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |